Olivia I Okereke1, Ankura Singh2. 1. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States; Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115 United States. Electronic address: ookereke@partners.org. 2. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Abstract
BACKGROUND: In this article, we review current evidence regarding potential benefits of vitamin D for improving mood and reducing depression risk in older adults. We summarize gaps in knowledge and describe future efforts that may clarify the role of vitamin D in late-life depression prevention. METHODS: MEDLINE and PsychINFO databases were searched for all articles on vitamin D and mood that had been published up to and including May 2015. Observational studies and randomized trials with 50 or more participants were included. We excluded studies that involved only younger adults and/or exclusively involved persons with current depression. RESULTS: Twenty observational (cross-sectional and prospective) studies and 10 randomized trials (nine were randomized placebo-controlled trials [RCTs]; one was a randomized blinded comparison trial) were reviewed. Inverse associations of vitamin D blood level or vitamin D intake with depression were found in 13 observational studies; three identified prospective relations. Results from all but one of the RCTs showed no statistically significant differences in depression outcomes between vitamin D and placebo groups. LIMITATIONS: Observational studies were mostly cross-sectional and frequently lacked adequate control of confounding. RCTs often featured low treatment doses, suboptimal post-intervention changes in biochemical levels of vitamin D, and/or short trial durations. CONCLUSION: Vitamin D level-mood associations were observed in most, but not all, observational studies; results indicated that vitamin D deficiency may be a risk factor for late-life depression. However, additional data from well-designed RCTs are required to determine the impact of vitamin D in late-life depression prevention.
BACKGROUND: In this article, we review current evidence regarding potential benefits of vitamin D for improving mood and reducing depression risk in older adults. We summarize gaps in knowledge and describe future efforts that may clarify the role of vitamin D in late-life depression prevention. METHODS: MEDLINE and PsychINFO databases were searched for all articles on vitamin D and mood that had been published up to and including May 2015. Observational studies and randomized trials with 50 or more participants were included. We excluded studies that involved only younger adults and/or exclusively involved persons with current depression. RESULTS: Twenty observational (cross-sectional and prospective) studies and 10 randomized trials (nine were randomized placebo-controlled trials [RCTs]; one was a randomized blinded comparison trial) were reviewed. Inverse associations of vitamin D blood level or vitamin D intake with depression were found in 13 observational studies; three identified prospective relations. Results from all but one of the RCTs showed no statistically significant differences in depression outcomes between vitamin D and placebo groups. LIMITATIONS: Observational studies were mostly cross-sectional and frequently lacked adequate control of confounding. RCTs often featured low treatment doses, suboptimal post-intervention changes in biochemical levels of vitamin D, and/or short trial durations. CONCLUSION:Vitamin D level-mood associations were observed in most, but not all, observational studies; results indicated that vitamin D deficiency may be a risk factor for late-life depression. However, additional data from well-designed RCTs are required to determine the impact of vitamin D in late-life depression prevention.
Authors: A M Grant; A Avenell; M K Campbell; A M McDonald; G S MacLennan; G C McPherson; F H Anderson; C Cooper; R M Francis; C Donaldson; W J Gillespie; C M Robinson; D J Torgerson; W A Wallace Journal: Lancet Date: 2005 May 7-13 Impact factor: 79.321
Authors: Heidi T May; Tami L Bair; Donald L Lappé; Jeffrey L Anderson; Benjamin D Horne; John F Carlquist; Joseph B Muhlestein Journal: Am Heart J Date: 2010-06 Impact factor: 4.749
Authors: Maris Kuningas; Simon P Mooijaart; Jelle Jolles; P Eline Slagboom; Rudi G J Westendorp; Diana van Heemst Journal: Neurobiol Aging Date: 2007-08-21 Impact factor: 4.673
Authors: Olivia I Okereke; Charles F Reynolds; David Mischoulon; Grace Chang; Nancy R Cook; Trisha Copeland; Georgina Friedenberg; Julie E Buring; JoAnn E Manson Journal: Contemp Clin Trials Date: 2018-03-08 Impact factor: 2.226
Authors: Chinnappa A Uthaiah; Narasimha M Beeraka; R Rajalakshmi; C M Ramya; SubbaRao V Madhunapantula Journal: Mol Neurobiol Date: 2022-04-27 Impact factor: 5.590
Authors: Mariska Bot; Ingeborg A Brouwer; Miquel Roca; Elisabeth Kohls; Brenda W J H Penninx; Ed Watkins; Gerard van Grootheest; Mieke Cabout; Ulrich Hegerl; Margalida Gili; Matthew Owens; Marjolein Visser Journal: JAMA Date: 2019-03-05 Impact factor: 56.272
Authors: Olivia I Okereke; Charles F Reynolds; David Mischoulon; Grace Chang; Chirag M Vyas; Nancy R Cook; Alison Weinberg; Vadim Bubes; Trisha Copeland; Georgina Friedenberg; I-Min Lee; Julie E Buring; JoAnn E Manson Journal: JAMA Date: 2020-08-04 Impact factor: 56.272
Authors: G Pagliai; F Sofi; F Vannetti; S Caiani; G Pasquini; R Molino Lova; F Cecchi; S Sorbi; C Macchi Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Lars Rejnmark; Lise Sofie Bislev; Kevin D Cashman; Gudny Eiríksdottir; Martin Gaksch; Martin Grübler; Guri Grimnes; Vilmundur Gudnason; Paul Lips; Stefan Pilz; Natasja M van Schoor; Mairead Kiely; Rolf Jorde Journal: PLoS One Date: 2017-07-07 Impact factor: 3.240